Shareholding disclosure

Deutsche Bank AG

Declared position

3.04%

Threshold

Crossed upwards

Timeline

Published

11.07.2020

Transaction

03.07.2020

Voting rights breakdown

Voting rights acquired3.04%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK79000C2

Beneficial owner

Deutsche Bank AG

Declared address

DEUTSCHE BANK AKTIENGESELLSCHAFT, 60325 Frankfurt am Main

Equity collateral received via transfer of title.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Deutsche Bank AG

Vifor Pharma AG11.07.2020TAK79000C2

Disclosure summary

Deutsche Bank AG disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 11.07.2020, at 3.04% of voting rights. Notice category: Single shareholder.

Disclosed position

3.04%

Voting rights acquired

Voting rights acquired3.04%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Deutsche Bank AG disclosed a holding in Vifor Pharma AG, published on 11.07.2020.

Publication date11.07.2020

Transaction date03.07.2020

Issuing companyVifor Pharma AG

Beneficial ownerDeutsche Bank AG

Declared addressDEUTSCHE BANK AKTIENGESELLSCHAFT, 60325 Frankfurt am Main

CategorySingle shareholder

Voting rights acquired3.04%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAK79000C2

Conditions

Equity collateral received via transfer of title.

Source: SIX Exchange Regulation · Publication date: 11.07.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open